Lambrini Galani

724 total citations
14 papers, 545 citations indexed

About

Lambrini Galani is a scholar working on Epidemiology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Lambrini Galani has authored 14 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Molecular Medicine and 4 papers in Infectious Diseases. Recurrent topics in Lambrini Galani's work include Antibiotic Resistance in Bacteria (5 papers), Urinary Tract Infections Management (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Lambrini Galani is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Urinary Tract Infections Management (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Lambrini Galani collaborates with scholars based in Greece, United States and Sweden. Lambrini Galani's co-authors include Helen Giamarellou, Ilias Karaiskos, Fotini Baziaka, Vissaria Sakka, Maria Souli, Anastasia Antoniadou, Sotirios Tsiodras, Irene Galani, Nikolaos Siafakas and Loukia Zerva and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Lambrini Galani

14 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lambrini Galani Greece 10 318 207 199 108 94 14 545
Indran Balakrishnan United Kingdom 12 206 0.6× 220 1.1× 115 0.6× 84 0.8× 77 0.8× 23 456
Mohamad Yasmin United States 11 255 0.8× 135 0.7× 150 0.8× 81 0.8× 90 1.0× 20 410
Marcello Meledandri Italy 11 314 1.0× 178 0.9× 158 0.8× 98 0.9× 105 1.1× 14 502
Kelley A. Gordon United States 10 196 0.6× 341 1.6× 104 0.5× 98 0.9× 41 0.4× 11 486
D. J. Farrell United States 8 178 0.6× 297 1.4× 111 0.6× 106 1.0× 42 0.4× 14 512
Alan T. Evangelista United States 13 242 0.8× 565 2.7× 283 1.4× 119 1.1× 96 1.0× 27 759
Renée S. Blosser-Middleton United States 14 167 0.5× 277 1.3× 164 0.8× 119 1.1× 48 0.5× 17 460
Donatella Lombardo Italy 11 289 0.9× 168 0.8× 163 0.8× 125 1.2× 133 1.4× 19 551
Laurie J. Kelly United States 9 321 1.0× 627 3.0× 209 1.1× 84 0.8× 113 1.2× 16 905
M.J. Rodríguez-Hernández Spain 11 198 0.6× 220 1.1× 114 0.6× 68 0.6× 95 1.0× 12 528

Countries citing papers authored by Lambrini Galani

Since Specialization
Citations

This map shows the geographic impact of Lambrini Galani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lambrini Galani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lambrini Galani more than expected).

Fields of papers citing papers by Lambrini Galani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lambrini Galani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lambrini Galani. The network helps show where Lambrini Galani may publish in the future.

Co-authorship network of co-authors of Lambrini Galani

This figure shows the co-authorship network connecting the top 25 collaborators of Lambrini Galani. A scholar is included among the top collaborators of Lambrini Galani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lambrini Galani. Lambrini Galani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Karaiskos, Ilias, et al.. (2019). Oral fosfomycin for the treatment of chronic bacterial prostatitis. Journal of Antimicrobial Chemotherapy. 74(5). 1430–1437. 38 indexed citations
2.
Souli, Maria, et al.. (2017). Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1305–1315. 44 indexed citations
3.
Karaiskos, Ilias, Lena E. Friberg, Lambrini Galani, et al.. (2016). Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration. International Journal of Antimicrobial Agents. 48(3). 337–341. 24 indexed citations
4.
Plachouras, Diamantis, Anastasia Antoniadou, Efthymia Giannitsioti, et al.. (2014). Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece. BMC Public Health. 14(1). 866–866. 22 indexed citations
5.
Giamarellou, Helen, Lambrini Galani, Fotini Baziaka, & Ilias Karaiskos. (2013). Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 57(5). 2388–2390. 105 indexed citations
6.
Karaiskos, Ilias, Lambrini Galani, Fotini Baziaka, & Helen Giamarellou. (2013). Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. International Journal of Antimicrobial Agents. 41(6). 499–508. 131 indexed citations
7.
Karaiskos, Ilias, Lambrini Galani, Fotini Baziaka, et al.. (2013). Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. International Journal of Antimicrobial Agents. 41(5). 480–483. 41 indexed citations
8.
Papadopoulos, Antonios, Bart Ferwerda, Anastasia Antoniadou, et al.. (2012). Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection. Cytokine. 60(1). 104–107. 5 indexed citations
9.
Papadopoulos, Antonios, Bart Ferwerda, Anastasia Antoniadou, et al.. (2010). Association of Toll‐Like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms with Increased Infection Risk in Patients with Advanced HIV‐1 Infection. Clinical Infectious Diseases. 51(2). 242–247. 25 indexed citations
10.
Panagopoulos, P., Anastasia Antoniadou, K. Kanellakopoulou, et al.. (2009). Fluoroquinolone Treatment of Chronic Bacterial Prostatitis: A Prospective Cohort Study. Journal of Chemotherapy. 21(3). 317–321. 8 indexed citations
11.
Souli, Maria, Vissaria Sakka, Irene Galani, et al.. (2008). Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis. International Journal of Antimicrobial Agents. 33(2). 137–142. 23 indexed citations
12.
Galani, Lambrini, Angelos Pefanis, Vissaria Sakka, et al.. (2008). Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents. 33(1). 65–69. 4 indexed citations
13.
Sakka, Vissaria, Sotirios Tsiodras, Lambrini Galani, et al.. (2007). Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clinical Microbiology and Infection. 14(1). 14–21. 72 indexed citations
14.
Sakka, Vissaria, Lambrini Galani, Angelos Pefanis, et al.. (2005). Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis. Journal of Antimicrobial Chemotherapy. 56(6). 1160–1162. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026